Assessing the robustness of radiomics/deep learning approach in the identification of efficacy of anti–PD-1 treatment in advanced or metastatic non-small cell lung carcinoma patients

RT @MlOncology: Assessing the robustness of radiomics/deep learning approach in the identification of efficacy of anti-PD-1 treatment in ad…

Assessing the robustness of radiomics/deep learning approach in the identification of efficacy of anti-PD-1 treatment in advanced or metastatic non-small cell lung carcinoma patients https://t.co/LoEzMtXCD0

RT @DrImranSheikh: Assessing the robustness of radiomics/deep learning approach in the identification of efficacy of anti–PD-1 treatment in…

RT @DrImranSheikh: Assessing the robustness of radiomics/deep learning approach in the identification of efficacy of anti–PD-1 treatment in…